Source: Investing.com ↗

Baird reiterates Lexeo Therapeutics stock rating on acquisition deal

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

+0.01%

BTC/USDT

$86,188.61

+0.44%

ETH/USDT

$2,733.67

-0.84%

XRP/USDT

$1.56

+4.19%

ZEC/USDT

$1,549.87

+3.61%